APO Research, Inc.

APO RESEARCH · REPORT

Neutral Alternative Protein

Alternative proteins, such as plant-based meat substitutes and edible insects, provide a substantial amount of protein but require less natural inputs to produce then the most common protein sources, meat and fish. Composed of different sequences of amino acids, proteins are found in almost all whole foods. Protein is responsible for building lean body tissue and providing the elements needed for digestive enzymes. Certain plant-based proteins offer functionality but pose flavor challenges. Pea protein is becoming more popular in part because of its neutral flavor.

Product & engineering

Understand the product.

Alternative proteins, such as plant-based meat substitutes and edible insects, provide a substantial amount of protein but require less natural inputs to produce then the most common protein sources, meat and fish. Composed of different sequences of amino acids, proteins are found in almost all whole foods. Protein is responsible for building lean body tissue and providing the elements needed for digestive enzymes. Certain plant-based proteins offer functionality but pose flavor challenges. Pea protein is becoming more popular in part because of its neutral flavor.

Selected research

Market Structure

Global Neutral Alternative Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

Alternative proteins, such as plant-based meat substitutes and edible insects, provide a substantial amount of protein but require less natural inputs to produce then the most common protein sources, meat and fish. Composed of different sequences of amino acids, proteins are found in almost all whole foods. Protein is responsible for building lean body tissue and providing the elements needed for digestive enzymes. Certain plant-based proteins offer functionality but pose flavor challenges. Pea protein is becoming more popular in part because of its neutral flavor.

Global Neutral Alternative Protein key players include Kerry, Cargill, Archer Daniels Midland, Glanbia, CHS etc. Global top five manufacturers hold a share over 30%.

North America is the largest market, with a share over 35%, followed by Europe and Asia-Pacific, both have a share over 40% percent.

Read the full market overview

In terms of product, Plant Protein is the largest segment, with a share over 50%. And in terms of application, the largest application is Food & Beverage followed by Healthcare Product.

This report provides an overview of the global Neutral Alternative Protein market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neutral Alternative Protein and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neutral Alternative Protein sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Neutral Alternative Protein market size, projected growth trends, production technologies, key applications, and end-use industries.

Neutral Alternative Protein Segment by Company

Kerry

Cargill

Archer Daniels Midland

Glanbia

CHS

Tereos Syral

CP Kelco

Davisco

Meelunie

DuPont

MGP Ingredient

Taj Agro Product

Glico Nutrition

Neutral Alternative Protein Segment by Type

Plant Protein

Insect Protein

Algae Protein

Others

Neutral Alternative Protein Segment by Application

Food & Beverage

Healthcare product

Neutral Alternative Protein Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neutral Alternative Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neutral Alternative Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neutral Alternative Protein.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Neutral Alternative Protein market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neutral Alternative Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Neutral Alternative Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Neutral Alternative Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Neutral Alternative Protein Industry Trends Table 2. Neutral Alternative Protein Industry Drivers Table 3. Neutral Alternative Protein Industry Opportunities and Challenges Table 4. Neutral Alternative Protein Industry Restraints Table 5. Global Neutral Alternative Protein Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Neutral Alternative Protein Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Neutral Alternative Protein Sales by Manufacturers (K MT) & (2021-2026) Table 8. Global Neutral Alternative Protein Sales Market Share by Manufacturers Table 9. Global Neutral Alternative Protein Average Sales Price (USD/MT) of Manufacturers (2021-2026) Table 10. Global Neutral Alternative Protein Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Neutral Alternative Protein Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Neutral Alternative Protein Manufacturers, Product Type & Application Table 13. Global Neutral Alternative Protein Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Neutral Alternative Protein by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Plant Protein Table 17. Major Manufacturers of Insect Protein Table 18. Major Manufacturers of Algae Protein Table 19. Major Manufacturers of Others Table 20. Global Neutral Alternative Protein Sales by Type 2021 VS 2025 VS 2032 (K MT) Table 21. Global Neutral Alternative Protein Sales by Type (2021-2026) & (K MT) Table 22. Global Neutral Alternative Protein Sales by Type (2027-2032) & (K MT) Table 23. Global Neutral Alternative Protein Sales Market Share by Type (2021-2026) Table 24. Global Neutral Alternative Protein Sales Market Share by Type (2027-2032) Table 25. Global Neutral Alternative Protein Revenue by Type 2021 VS 2025 VS 2032 (K MT) Table 26. Global Neutral Alternative Protein Revenue by Type (2021-2026) & (K MT) Table 27. Global Neutral Alternative Protein Revenue by Type (2027-2032) & (K MT) Table 28. Global Neutral Alternative Protein Revenue Market Share by Type (2021-2026) Table 29. Global Neutral Alternative Protein Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Food & Beverage Table 31. Major Manufacturers of Healthcare product Table 32. Global Neutral Alternative Protein Sales by Application 2021 VS 2025 VS 2032 (K MT) Table 33. Global Neutral Alternative Protein Sales by Application (2021-2026) & (K MT) Table 34. Global Neutral Alternative Protein Sales by Application (2027-2032) & (K MT) Table 35. Global Neutral Alternative Protein Sales Market Share by Application (2021-2026) Table 36. Global Neutral Alternative Protein Sales Market Share by Application (2027-2032) Table 37. Global Neutral Alternative Protein Revenue by Application 2021 VS 2025 VS 2032 (K MT) Table 38. Global Neutral Alternative Protein Revenue by Application (2021-2026) & (K MT) Table 39. Global Neutral Alternative Protein Revenue by Application (2027-2032) & (K MT) Table 40. Global Neutral Alternative Protein Revenue Market Share by Application (2021-2026) Table 41. Global Neutral Alternative Protein Revenue Market Share by Application (2027-2032) Table 42. Global Neutral Alternative Protein Sales by Region: 2021 VS 2025 VS 2032 (K MT) Table 43. Global Neutral Alternative Protein Sales by Region (2021-2026) & (K MT) Table 44. Global Neutral Alternative Protein Sales Market Share by Region (2021-2026) Table 45. Global Neutral Alternative Protein Sales Forecasted by Region (2027-2032) & (K MT) Table 46. Global Neutral Alternative Protein Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Neutral Alternative Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K MT) Table 48. North America Neutral Alternative Protein Sales by Country (2021-2026) & (K MT) Table 49. North America Neutral Alternative Protein Sales by Country (2027-2032) & (K MT) Table 50. Europe Neutral Alternative Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K MT) Table 51. Europe Neutral Alternative Protein Sales by Country (2021-2026) & (K MT) Table 52. Europe Neutral Alternative Protein Sales by Country (2027-2032) & (K MT) Table 53. Asia Pacific Neutral Alternative Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K MT) Table 54. Asia Pacific Neutral Alternative Protein Sales by Country (2021-2026) & (K MT) Table 55. Asia Pacific Neutral Alternative Protein Sales by Country (2027-2032) & (K MT) Table 56. South America, Middle East and Africa Neutral Alternative Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K MT) Table 57. South America, Middle East and Africa Neutral Alternative Protein Sales by Country (2021-2026) & (K MT) Table 58. South America, Middle East and Africa Neutral Alternative Protein Sales by Country (2027-2032) & (K MT) Table 59. Global Neutral Alternative Protein Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Neutral Alternative Protein Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Neutral Alternative Protein Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Neutral Alternative Protein Revenue Market Share by Region (2021-2026) Table 63. Global Neutral Alternative Protein Revenue Market Share by Region (2027-2032) Table 64. Kerry Company Information Table 65. Kerry Business Overview Table 66. Kerry Neutral Alternative Protein Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Kerry Neutral Alternative Protein Product Portfolio Table 68. Kerry Recent Development Table 69. Cargill Company Information Table 70. Cargill Business Overview Table 71. Cargill Neutral Alternative Protein Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Cargill Neutral Alternative Protein Product Portfolio Table 73. Cargill Recent Development Table 74. Archer Daniels Midland Company Information Table 75. Archer Daniels Midland Business Overview Table 76. Archer Daniels Midland Neutral Alternative Protein Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Archer Daniels Midland Neutral Alternative Protein Product Portfolio Table 78. Archer Daniels Midland Recent Development Table 79. Glanbia Company Information Table 80. Glanbia Business Overview Table 81. Glanbia Neutral Alternative Protein Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Glanbia Neutral Alternative Protein Product Portfolio Table 83. Glanbia Recent Development Table 84. CHS Company Information Table 85. CHS Business Overview Table 86. CHS Neutral Alternative Protein Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. CHS Neutral Alternative Protein Product Portfolio Table 88. CHS Recent Development Table 89. Tereos Syral Company Information Table 90. Tereos Syral Business Overview Table 91. Tereos Syral Neutral Alternative Protein Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Tereos Syral Neutral Alternative Protein Product Portfolio Table 93. Tereos Syral Recent Development Table 94. CP Kelco Company Information Table 95. CP Kelco Business Overview Table 96. CP Kelco Neutral Alternative Protein Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. CP Kelco Neutral Alternative Protein Product Portfolio Table 98. CP Kelco Recent Development Table 99. Davisco Company Information Table 100. Davisco Business Overview Table 101. Davisco Neutral Alternative Protein Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Davisco Neutral Alternative Protein Product Portfolio Table 103. Davisco Recent Development Table 104. Meelunie Company Information Table 105. Meelunie Business Overview Table 106. Meelunie Neutral Alternative Protein Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Meelunie Neutral Alternative Protein Product Portfolio Table 108. Meelunie Recent Development Table 109. DuPont Company Information Table 110. DuPont Business Overview Table 111. DuPont Neutral Alternative Protein Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. DuPont Neutral Alternative Protein Product Portfolio Table 113. DuPont Recent Development Table 114. MGP Ingredient Company Information Table 115. MGP Ingredient Business Overview Table 116. MGP Ingredient Neutral Alternative Protein Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. MGP Ingredient Neutral Alternative Protein Product Portfolio Table 118. MGP Ingredient Recent Development Table 119. Taj Agro Product Company Information Table 120. Taj Agro Product Business Overview Table 121. Taj Agro Product Neutral Alternative Protein Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Taj Agro Product Neutral Alternative Protein Product Portfolio Table 123. Taj Agro Product Recent Development Table 124. Glico Nutrition Company Information Table 125. Glico Nutrition Business Overview Table 126. Glico Nutrition Neutral Alternative Protein Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Glico Nutrition Neutral Alternative Protein Product Portfolio Table 128. Glico Nutrition Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Neutral Alternative Protein Distributors List Table 132. Neutral Alternative Protein Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Neutral Alternative Protein Product Image Figure 2. Global Neutral Alternative Protein Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neutral Alternative Protein Market Size (2021-2032) & (US$ Million) Figure 4. Global Neutral Alternative Protein Sales (2021-2032) & (K MT) Figure 5. Global Neutral Alternative Protein Average Price (USD/MT) & (2021-2032) Figure 6. Global Top 5 and 10 Neutral Alternative Protein Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Plant Protein Image Figure 9. Insect Protein Image Figure 10. Algae Protein Image Figure 11. Others Image Figure 12. Global Neutral Alternative Protein Sales by Type (2021 VS 2025 VS 2032) & (K MT) Figure 13. Global Neutral Alternative Protein Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Neutral Alternative Protein Sales Market Share by Type (2021-2032) Figure 15. Global Neutral Alternative Protein Revenue by Type (2021 VS 2025 VS 2032) & (K MT) Figure 16. Global Neutral Alternative Protein Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Neutral Alternative Protein Revenue Market Share by Type (2021-2032) Figure 18. Food & Beverage Image Figure 19. Healthcare product Image Figure 20. Global Neutral Alternative Protein Sales by Application (2021 VS 2025 VS 2032) & (K MT) Figure 21. Global Neutral Alternative Protein Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Neutral Alternative Protein Sales Market Share by Application (2021-2032) Figure 23. Global Neutral Alternative Protein Revenue by Application (2021 VS 2025 VS 2032) & (K MT) Figure 24. Global Neutral Alternative Protein Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Neutral Alternative Protein Revenue Market Share by Application (2021-2032) Figure 26. North America Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 27. North America Neutral Alternative Protein Sales Market Share by Country (2021-2032) Figure 28. U.S. Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 29. Canada Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 30. Mexico Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 31. Europe Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 32. Europe Neutral Alternative Protein Sales Market Share by Country (2021-2032) Figure 33. Germany Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 34. France Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 35. U.K. Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 36. Italy Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 37. Netherlands Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 38. Asia Pacific Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 39. Asia Pacific Neutral Alternative Protein Sales Market Share by Country (2021-2032) Figure 40. China Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 41. Japan Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 42. South Korea Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 43. Southeast Asia Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 44. India Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 45. Australia Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 46. South America, Middle East and Africa Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 47. South America, Middle East and Africa Neutral Alternative Protein Sales Market Share by Country (2021-2032) Figure 48. Brazil Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 49. South Africa Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 50. Saudi Arabia Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 51. Turkey Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 52. Argentina Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 53. UAE Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 54. Egypt Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 55. Chile Neutral Alternative Protein Sales and Growth Rate (2021-2032) & (K MT) Figure 56. Global Neutral Alternative Protein Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Neutral Alternative Protein Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Neutral Alternative Protein Revenue (2021-2032) & (US$ Million) Figure 59. North America Neutral Alternative Protein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Neutral Alternative Protein Revenue (2021-2032) & (US$ Million) Figure 61. Europe Neutral Alternative Protein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Neutral Alternative Protein Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Neutral Alternative Protein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Neutral Alternative Protein Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Neutral Alternative Protein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Neutral Alternative Protein Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Neutral Alternative Protein Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Plant Protein
  • Insect Protein
  • Algae Protein
  • Others
Applications
  • Food & Beverage
  • Healthcare product
Companies covered
  • Kerry
  • Cargill
  • Archer Daniels Midland
  • Glanbia
  • CHS
  • Tereos Syral
  • CP Kelco
  • Davisco
  • Meelunie
  • DuPont
  • MGP Ingredient
  • Taj Agro Product
  • Glico Nutrition

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Neutral Alternative Protein Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Neutral Alternative Protein Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Neutral Alternative Protein Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Neutral Alternative Protein Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Neutral Alternative Protein Market Dynamics
  1. 2.1 Neutral Alternative Protein Industry Trends
  2. 2.2 Neutral Alternative Protein Industry Drivers
  3. 2.3 Neutral Alternative Protein Industry Opportunities and Challenges
  4. 2.4 Neutral Alternative Protein Industry Restraints
3 Neutral Alternative Protein Market by Manufacturers
  1. 3.1 Global Neutral Alternative Protein Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Neutral Alternative Protein Sales by Manufacturers (2021-2026)
  3. 3.3 Global Neutral Alternative Protein Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Neutral Alternative Protein Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neutral Alternative Protein Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Neutral Alternative Protein Manufacturers, Product Type & Application
  7. 3.7 Global Neutral Alternative Protein Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neutral Alternative Protein Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neutral Alternative Protein Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neutral Alternative Protein Tier 1, Tier 2, and Tier 3
4 Neutral Alternative Protein Market by Type
  1. 4.1 Neutral Alternative Protein Type Introduction
  2. 4.1.1 Plant Protein
  3. 4.1.2 Insect Protein
  4. 4.1.3 Algae Protein
  5. 4.1.4 Others
  6. 4.2 Global Neutral Alternative Protein Sales by Type
  7. 4.2.1 Global Neutral Alternative Protein Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Neutral Alternative Protein Sales by Type (2021-2032)
  9. 4.2.3 Global Neutral Alternative Protein Sales Market Share by Type (2021-2032)
  10. 4.3 Global Neutral Alternative Protein Revenue by Type
  11. 4.3.1 Global Neutral Alternative Protein Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Neutral Alternative Protein Revenue by Type (2021-2032)
  13. 4.3.3 Global Neutral Alternative Protein Revenue Market Share by Type (2021-2032)
5 Neutral Alternative Protein Market by Application
  1. 5.1 Neutral Alternative Protein Application Introduction
  2. 5.1.1 Food & Beverage
  3. 5.1.2 Healthcare product
  4. 5.2 Global Neutral Alternative Protein Sales by Application
  5. 5.2.1 Global Neutral Alternative Protein Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Neutral Alternative Protein Sales by Application (2021-2032)
  7. 5.2.3 Global Neutral Alternative Protein Sales Market Share by Application (2021-2032)
  8. 5.3 Global Neutral Alternative Protein Revenue by Application
  9. 5.3.1 Global Neutral Alternative Protein Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Neutral Alternative Protein Revenue by Application (2021-2032)
  11. 5.3.3 Global Neutral Alternative Protein Revenue Market Share by Application (2021-2032)
6 Global Neutral Alternative Protein Sales by Region
  1. 6.1 Global Neutral Alternative Protein Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neutral Alternative Protein Sales by Region (2021-2032)
  3. 6.2.1 Global Neutral Alternative Protein Sales by Region (2021-2026)
  4. 6.2.2 Global Neutral Alternative Protein Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Neutral Alternative Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Neutral Alternative Protein Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Neutral Alternative Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Neutral Alternative Protein Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Neutral Alternative Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Neutral Alternative Protein Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Neutral Alternative Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Neutral Alternative Protein Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Neutral Alternative Protein Revenue by Region
  1. 7.1 Global Neutral Alternative Protein Revenue by Region
  2. 7.1.1 Global Neutral Alternative Protein Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Neutral Alternative Protein Revenue by Region (2021-2026)
  4. 7.1.3 Global Neutral Alternative Protein Revenue by Region (2027-2032)
  5. 7.1.4 Global Neutral Alternative Protein Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Neutral Alternative Protein Revenue (2021-2032)
  8. 7.2.2 North America Neutral Alternative Protein Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Neutral Alternative Protein Revenue (2021-2032)
  11. 7.3.2 Europe Neutral Alternative Protein Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Neutral Alternative Protein Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Neutral Alternative Protein Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Neutral Alternative Protein Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Neutral Alternative Protein Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Kerry
  2. 8.1.1 Kerry Company Information
  3. 8.1.2 Kerry Business Overview
  4. 8.1.3 Kerry Neutral Alternative Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Kerry Neutral Alternative Protein Product Portfolio
  6. 8.1.5 Kerry Recent Developments
  7. 8.2 Cargill
  8. 8.2.1 Cargill Company Information
  9. 8.2.2 Cargill Business Overview
  10. 8.2.3 Cargill Neutral Alternative Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cargill Neutral Alternative Protein Product Portfolio
  12. 8.2.5 Cargill Recent Developments
  13. 8.3 Archer Daniels Midland
  14. 8.3.1 Archer Daniels Midland Company Information
  15. 8.3.2 Archer Daniels Midland Business Overview
  16. 8.3.3 Archer Daniels Midland Neutral Alternative Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Archer Daniels Midland Neutral Alternative Protein Product Portfolio
  18. 8.3.5 Archer Daniels Midland Recent Developments
  19. 8.4 Glanbia
  20. 8.4.1 Glanbia Company Information
  21. 8.4.2 Glanbia Business Overview
  22. 8.4.3 Glanbia Neutral Alternative Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Glanbia Neutral Alternative Protein Product Portfolio
  24. 8.4.5 Glanbia Recent Developments
  25. 8.5 CHS
  26. 8.5.1 CHS Company Information
  27. 8.5.2 CHS Business Overview
  28. 8.5.3 CHS Neutral Alternative Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CHS Neutral Alternative Protein Product Portfolio
  30. 8.5.5 CHS Recent Developments
  31. 8.6 Tereos Syral
  32. 8.6.1 Tereos Syral Company Information
  33. 8.6.2 Tereos Syral Business Overview
  34. 8.6.3 Tereos Syral Neutral Alternative Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Tereos Syral Neutral Alternative Protein Product Portfolio
  36. 8.6.5 Tereos Syral Recent Developments
  37. 8.7 CP Kelco
  38. 8.7.1 CP Kelco Company Information
  39. 8.7.2 CP Kelco Business Overview
  40. 8.7.3 CP Kelco Neutral Alternative Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CP Kelco Neutral Alternative Protein Product Portfolio
  42. 8.7.5 CP Kelco Recent Developments
  43. 8.8 Davisco
  44. 8.8.1 Davisco Company Information
  45. 8.8.2 Davisco Business Overview
  46. 8.8.3 Davisco Neutral Alternative Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Davisco Neutral Alternative Protein Product Portfolio
  48. 8.8.5 Davisco Recent Developments
  49. 8.9 Meelunie
  50. 8.9.1 Meelunie Company Information
  51. 8.9.2 Meelunie Business Overview
  52. 8.9.3 Meelunie Neutral Alternative Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Meelunie Neutral Alternative Protein Product Portfolio
  54. 8.9.5 Meelunie Recent Developments
  55. 8.10 DuPont
  56. 8.10.1 DuPont Company Information
  57. 8.10.2 DuPont Business Overview
  58. 8.10.3 DuPont Neutral Alternative Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 DuPont Neutral Alternative Protein Product Portfolio
  60. 8.10.5 DuPont Recent Developments
  61. 8.11 MGP Ingredient
  62. 8.11.1 MGP Ingredient Company Information
  63. 8.11.2 MGP Ingredient Business Overview
  64. 8.11.3 MGP Ingredient Neutral Alternative Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 MGP Ingredient Neutral Alternative Protein Product Portfolio
  66. 8.11.5 MGP Ingredient Recent Developments
  67. 8.12 Taj Agro Product
  68. 8.12.1 Taj Agro Product Company Information
  69. 8.12.2 Taj Agro Product Business Overview
  70. 8.12.3 Taj Agro Product Neutral Alternative Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Taj Agro Product Neutral Alternative Protein Product Portfolio
  72. 8.12.5 Taj Agro Product Recent Developments
  73. 8.13 Glico Nutrition
  74. 8.13.1 Glico Nutrition Company Information
  75. 8.13.2 Glico Nutrition Business Overview
  76. 8.13.3 Glico Nutrition Neutral Alternative Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Glico Nutrition Neutral Alternative Protein Product Portfolio
  78. 8.13.5 Glico Nutrition Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Neutral Alternative Protein Value Chain Analysis
  2. 9.1.1 Neutral Alternative Protein Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Neutral Alternative Protein Production Mode & Process
  6. 9.2 Neutral Alternative Protein Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Neutral Alternative Protein Distributors
  9. 9.2.3 Neutral Alternative Protein Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.